期刊文献+
共找到53篇文章
< 1 2 3 >
每页显示 20 50 100
Regulation of bile acid receptor activity 被引量:7
1
作者 Yu-Jui Yvonne Wan Lili Sheng 《Liver Research》 2018年第4期180-185,共6页
Many receptors can be activated by bile acids(BAs)and their derivatives.These include nuclear receptors farnesoid X receptor(FXR),pregnane X receptor(PXR),and vitamin D receptor(VDR),as well as membrane receptors Take... Many receptors can be activated by bile acids(BAs)and their derivatives.These include nuclear receptors farnesoid X receptor(FXR),pregnane X receptor(PXR),and vitamin D receptor(VDR),as well as membrane receptors Takeda G protein receptor 5(TGR5),sphingosine-1-phosphate receptor 2(S1PR2),and cholinergic receptor muscarinic 2(CHRM2).All of them are implicated in the development of metabolic and immunological diseases in response to endobiotic and xenobiotic exposure.Because epigenetic regulation is critical for organisms to adapt to constant environmental changes,this review article summarizes epigenetic regulation as well as post-transcriptional modification of bile acid re-ceptors.In addition,the focus of this review is on the liver and digestive tract although these receptors may have effects on other organs.Those regulatory mechanisms are implicated in the disease process and critically important in uncovering innovative strategy for prevention and treatment of metabolic and immunological diseases. 展开更多
关键词 Bile acid receptor Farnesoid X receptor(FXR) G protein-coupled bile acid receptor Takeda G protein receptor 5(TGR5) sphingosine-1-phosphate receptor 2 (S1PR2) ACETYLATION Methylation GLYCOSYLATION
原文传递
S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung 被引量:2
2
作者 Mengyao Hao Rong Fu +13 位作者 Jun Tai Zhenhuan Tian Xia Yuan Yang Chen Mingjin Wang Huimin Jiang Ming Ji Fangfang Lai Nina Xue Liping Bai Yizhun Zhu Xiaoxi Lv Xiaoguang Chen Jing Jin 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第3期1110-1127,共18页
Idiopathic pulmonary fibrosis(IPF)is a progressive lung disease with unclear etiology and limited treatment options.The median survival time for IPF patients is approximately 2–3 years and there is no effective inter... Idiopathic pulmonary fibrosis(IPF)is a progressive lung disease with unclear etiology and limited treatment options.The median survival time for IPF patients is approximately 2–3 years and there is no effective intervention to treat IPF other than lung transplantation.As important components of lung tissue,endothelial cells(ECs)are associated with pulmonary diseases.However,the role of endothelial dysfunction in pulmonary fibrosis(PF)is incompletely understood.Sphingosine-1-phosphate receptor 1(S1PR1)is a G protein-coupled receptor highly expressed in lung ECs.Its expression is markedly reduced in patients with IPF.Herein,we generated an endothelial-conditional S1pr1 knockout mouse model which exhibited inflammation and fibrosis with or without bleomycin(BLM)challenge.Selective activation of S1PR1 with an S1PR1 agonist,IMMH002,exerted a potent therapeutic effect in mice with bleomycin-induced fibrosis by protecting the integrity of the endothelial barrier.These results suggest that S1PR1 might be a promising drug target for IPF therapy. 展开更多
关键词 Idiopathic pulmonary fibrosis Endothelial barrier Tight junction sphingosine-1-phosphate receptor 1 sphingosine-1-phosphate receptor 1 agonist FTY720 IMMH002 Protein stability
原文传递
Pharmacokinetics of H002, a novel S1PR_1 modulator, and its metabolites in rat blood using liquid chromatography–tandem mass spectrometry 被引量:5
3
作者 Jiaqi Mi Manman Zhao +6 位作者 Shu Yang Shuang Yang Jing Jin Xiaojian Wang Qiong Xiao Jinping Hu Yan Li 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2016年第6期576-583,共8页
A rapid and sensitive liquid chromatography–tandem mass spectrometry(LC–MS/MS) method was developed and validated for the simultaneous determination of H002 and its phosphorylated metabolite, H002-P and hydroxylated... A rapid and sensitive liquid chromatography–tandem mass spectrometry(LC–MS/MS) method was developed and validated for the simultaneous determination of H002 and its phosphorylated metabolite, H002-P and hydroxylated metabolite H002-M, in rat blood. H001, an analogue of H002, was used as the internal standard.Blood samples were prepared by simple protein precipitation. The analytes and internal standard were separated on a Zorbax SB-C18 column with a gradient mobile phase consisting of methanol and water containing 0.1% formic acid at a flow rate of 0.2 mL /min with an operating temperature of 20 1C. The detection was performed on a triple quadrupole tandem mass spectrometer with positive electrospray ionization in multiple-reaction monitoring mode.Linear detection responses were obtained from 0.2–100 ng/mL for H002 and H002-M, while 0.5–100 ng/mL for H002-P. The intra- and inter-day precision(RSD%) was within 11.76%, with the accuracy(RE%) ranging from –9.84% to 9.12%. The analytes were shown to be stable during sample storage, preparation and analytic procedures.The method was applied to determine the pharmacokinetics of H002 in rats, and a preliminary study showed that the pharmacokinetics of H002 correlated with its biological effect on peripheral blood lymphocytes. 展开更多
关键词 S1P receptor S1PR1 modulator sphingosine-1-phosphate S1P analogue Metabolite LC–MS/MS PHARMACOKINETICS Periphery blood lymphocyte
原文传递
淫羊藿苷对血管性勃起功能障碍大鼠的治疗效果及机制初探 被引量:1
4
作者 姚俊成 刘思巧 +4 位作者 颜天 王磊 李玉涛 杨祺 窦科 《海军军医大学学报》 CAS CSCD 北大核心 2023年第11期1373-1377,共5页
目的观察淫羊藿苷对血管性勃起功能障碍(ED)大鼠的治疗效果,并初步探究其作用机制。方法采用双侧髂内动脉结扎的方式构建血管性ED大鼠模型,将其随机分为5组,每组10只:模型组(每天1 mL生理盐水灌胃),他达拉非组(按每天0.8 mg/kg的剂量给... 目的观察淫羊藿苷对血管性勃起功能障碍(ED)大鼠的治疗效果,并初步探究其作用机制。方法采用双侧髂内动脉结扎的方式构建血管性ED大鼠模型,将其随机分为5组,每组10只:模型组(每天1 mL生理盐水灌胃),他达拉非组(按每天0.8 mg/kg的剂量给予他达拉非溶液灌胃),淫羊藿苷低、中、高剂量组(分别按每天20、40、80 mg/kg的剂量给予淫羊藿苷混悬液灌胃)。假手术组(10只)给予每天1 mL生理盐水灌胃。造模4周后,刺激大鼠阴茎海绵体神经,测量最大阴茎海绵体内压(ICPmax),评估大鼠的勃起功能。连续灌胃30 d后取大鼠阴茎海绵体标本,用ELISA法检测各组大鼠阴茎海绵体中α-平滑肌肌动蛋白(α-SMA)、鞘氨醇-1-磷酸(S1P)和鞘氨醇-1-磷酸受体1(S1PR1)的表达水平;采用Masson染色测定大鼠阴茎海绵体组织纤维化情况,计算所采集图像的积分光密度(IOD)。对各组大鼠ICPmax和阴茎海绵体中α-SMA、S1P、S1PR1水平进行线性回归分析。结果他达拉非组大鼠的ICPmax高于淫羊藿苷低剂量组,低于淫羊藿苷中、高剂量组(P均<0.05)。他达拉非组大鼠阴茎海绵体的Masson染色IOD低于淫羊藿苷低、中剂量组,高于淫羊藿苷高剂量组(P均<0.05)。他达拉非组大鼠阴茎海绵体中α-SMA的表达水平低于淫羊藿苷高剂量组,高于淫羊藿苷低、中剂量组(P均<0.05)。他达拉非组大鼠阴茎海绵体中S1P的表达水平低于淫羊藿苷中、高剂量组(P均<0.05)。他达拉非组大鼠阴茎海绵体中S1PR1表达水平低于淫羊藿苷低、中、高剂量组(P均<0.05)。线性回归分析结果显示,α-SMA、S1P、S1PR1水平和ICPmax之间存在线性关系(P均<0.05)。结论淫羊藿苷可显著改善血管性ED大鼠的勃起功能,其可能通过调节S1P、S1PR1水平促进血管内皮的新生和稳定,达到改善勃起功能的目的。 展开更多
关键词 淫羊藿苷 血管性勃起功能障碍 鞘氨醇-1-磷酸 鞘氨醇-1-磷酸受体1
下载PDF
Fingolimod protects against neurovascular unit injury in a rat model of focal cerebral ischemia/reperfusion injury 被引量:2
5
作者 Xiao-Yu Zhu Ting-Ting Ma +4 位作者 Yang Li Ming-Qi Zhang Liang Zhao Jia Liang Lian-Qiu Min 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第4期869-874,共6页
Recent research on the underlying mechanisms of cerebral ischemia indicates that the neurovascular unit can be used as a novel subject for general surveys of neuronal damage and protein mechanisms.Fingolimod(FTY-720)i... Recent research on the underlying mechanisms of cerebral ischemia indicates that the neurovascular unit can be used as a novel subject for general surveys of neuronal damage and protein mechanisms.Fingolimod(FTY-720)is a newly developed immunosuppressant isolated from Cordyceps sinensis that exhibits a wide range of biological activities,and has recently attracted much attention for the treatment of ischemic cerebrovascular diseases.In the current research,the role of FTY-720 and its possible mechanisms were assessed from an neurovascular unit perspective using a rat cerebral ischemia model.Our results revealed that FTY-720 markedly decreased infarct volume,promoted neurological function recovery,and weakened the blood-brain barrier permeability of ischemic rats.The protective roles of FTY-720 in ischemic stroke are ascribed to a combination of sphingosin-1-phosphate receptor-1 and reduced expression of sphingosin-1-phosphate receptor-1 in microvessels and reduction of interleukin-17A protein levels.These findings indicate that FTY-720 has promise as a new therapy for neurovascular protection and functional recovery after ischemic stroke. 展开更多
关键词 astrocyte blood-brain barrier CLAUDIN-5 FTY-720 INTERLEUKIN-17A ischemic stroke neural protection neurovascular unit OCCLUDIN sphingosine-1-phosphate receptor 1
下载PDF
Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases 被引量:4
6
作者 Eric K.Kwong Huiping Zhou 《Liver Research》 2019年第1期19-24,共6页
The liver is the central organ involved in lipid metabolism and the gastrointestinal(GI)tract is responsible for nutrient absorption and partitioning.Obesity,dyslipidemia and metabolic disorders are of increasing publ... The liver is the central organ involved in lipid metabolism and the gastrointestinal(GI)tract is responsible for nutrient absorption and partitioning.Obesity,dyslipidemia and metabolic disorders are of increasing public health concern worldwide,and novel therapeutics that target both the liver and the GI tract(gut-liver axis)are much needed.In addition to aiding fat digestion,bile acids act as important signaling molecules that regulate lipid,glucose and energy metabolism via activating nuclear receptor,G protein-coupled receptors(GPCRs),Takeda G protein receptor 5(TGR5)and sphingosine-1-phosphate receptor 2(S1PR2).Sphingosine-1-phosphate(S1P)is synthesized by two sphingosine kinase isoforms and is a potent signaling molecule that plays a critical role in various diseases such as fatty liver,in-flammatory bowel disease(IBD)and colorectal cancer.In this review,we will focus on recent findings related to the role of S1P-mediated signaling pathways in the gut-liver axis. 展开更多
关键词 sphingosine-1-phosphate(S1P) sphingosine kinase 2(SphK2) sphingosine-1-phosphate receptor 2 (S1PR2) Gut-liver axis Liver diseases
原文传递
背根神经节S1PR1在瑞芬太尼诱发切口痛大鼠痛觉过敏中的作用 被引量:1
7
作者 李洁 王春艳 +1 位作者 李清 于泳浩 《中华麻醉学杂志》 CAS CSCD 北大核心 2023年第1期62-66,共5页
目的评价背根神经节鞘氨醇-1-磷酸-1受体(S1PR1)在瑞芬太尼诱发切口痛大鼠痛觉过敏中的作用。方法取鞘内置管和尾静脉置管成功的雄性SD大鼠48只,体质量260~280 g,2~3月龄,采用随机数字表法分为6组(n=8):对照组(C组)、S1PR1拮抗剂组(F组... 目的评价背根神经节鞘氨醇-1-磷酸-1受体(S1PR1)在瑞芬太尼诱发切口痛大鼠痛觉过敏中的作用。方法取鞘内置管和尾静脉置管成功的雄性SD大鼠48只,体质量260~280 g,2~3月龄,采用随机数字表法分为6组(n=8):对照组(C组)、S1PR1拮抗剂组(F组)、瑞芬太尼组(R组)、瑞芬太尼+S1PR1拮抗剂组组(R+F组)、瑞芬太尼+切口痛组(R+I组)和瑞芬太尼+切口痛+S1PR1拮抗剂组(R+I+F组)。C组尾静脉输注生理盐水0.1 ml·kg^(-1)·min^(-1)60 min;R组尾静脉输注瑞芬太尼1.0μg·kg^(-1)·min^(-1)60 min;F组鞘内注射FTY7203 noml,10 min后尾静脉输注生理盐水1.0μg·kg^(-1)·min^(-1)60 min;R+F组鞘内注射FTY7203 nmol,10 min后尾静脉输注瑞芬太尼1.0μg·kg^(-1)·min^(-1)60 min;R+I组建立切口痛模型的同时尾静脉输注瑞芬太尼1.0μg·kg^(-1)·min^(-1)60 min;R+I+F组鞘内注射FTY7203 nmol,10 min后建立切口痛模型,同时尾静脉注射瑞芬太尼1.0μg·kg^(-1)·min^(-1)60 min。于输注瑞芬太尼或生理盐水前24 h和停止输注后2、6、24、48 h(T_(1~4))时测定机械缩足反应阈(MWT)和热缩足潜伏期(TWL)。最后1次测定痛阈后处死大鼠,取L4~6节段背根神经节,分别采用Western blot和q-PCR法测定S1PR1、NOD样受体热蛋白结构域相关蛋白3(NLRP3)、白细胞介素1β(IL-1β)和谷氨酸转运体-1(GLT-1)及其mRNA的表达水平。结果与C组比较,R组和RI组T1~4时MWT降低,TWL缩短,背根神经节S1PR1、NLRP3、IL-1β及其mRNA表达上调,GLT-1表达及其mRNA下调(P<0.05),F组上述指标差异无统计学意义(P>0.05)。与R组比较,R+I组T1~4时MWT降低,TWL缩短,背根神经节S1PR1、NLRP3、IL-1β及其mRNA表达上调,GLT-1表达及其mRNA下调,R+F组T1~4时MWT升高,TWL延长,背根神经节S1PR1、NLRP3、IL-1β及其mRNA表达下调,GLT-1及其mRNA表达上调(P<0.05)。与R+I组比较,R+I+F组T1~4时MWT升高,TWL延长,背根神经节S1PR1、NLRP3、IL-1β及其mRNA表达下调,GLT-1及其mRNA表达上调(P<0.05)。结论瑞芬� 展开更多
关键词 瑞芬太尼 痛觉过敏 疼痛 手术后 鞘氨醇-1-磷酸-1受体 神经节
原文传递
S1PR1基因慢病毒转染对EAE小鼠调节性T细胞及IL-17、IFN-γ水平的影响 被引量:3
8
作者 张瑶 李作孝 《中国免疫学杂志》 CAS CSCD 北大核心 2019年第11期1305-1309,共5页
目的:观察经外周转染S1PR1基因慢病毒(LV-S1PR1)对实验性自身免疫性脑脊髓炎(EAE)小鼠调节性T细胞比例及IL-17、IFN-γ水平的影响。方法:将30只健康雌性C57BL/6小鼠随机分为空白对照组、EAE模型组、LV-S1PR1转染组,后两组建立EAE模型,LV... 目的:观察经外周转染S1PR1基因慢病毒(LV-S1PR1)对实验性自身免疫性脑脊髓炎(EAE)小鼠调节性T细胞比例及IL-17、IFN-γ水平的影响。方法:将30只健康雌性C57BL/6小鼠随机分为空白对照组、EAE模型组、LV-S1PR1转染组,后两组建立EAE模型,LV-S1PR1转染组经尾静脉注射LV-S1PR1。每日进行神经功能缺损评分;免疫印迹法(Western blot)检测外周血S1PR1表达水平;ELISA法检测外周血1-磷酸鞘氨醇(S1P)水平以及脊髓组织IL-17、IFN-γ水平;流式细胞术检测脾脏中调节性T细胞的比例。结果:与EAE模型组相比较,LV-S1PR1转染组神经功能缺损症状改善;外周血S1PR1表达增加( P <0.05);外周血S1P水平、脾脏中调节性T细胞比例及脊髓组织中IL-17和IFN-γ水平降低( P <0.05)。结论:经外周转染LV-S1PR1可以改善EAE小鼠的发病,其防治作用机制可能与上调外周S1PR1的表达,降低外周S1P水平,使T细胞迁移受阻有关。 展开更多
关键词 S1PR1慢病毒 实验性自身免疫性脑脊髓炎 1-磷酸鞘氨醇 鞘氨醇-1-磷酸1型受体 小鼠
下载PDF
The contributions of bacteria metabolites to the development of hepatic encephalopathy
9
作者 Miranda Claire Gilbert Tahereh Setayesh Yu-Jui Yvonne Wan 《Liver Research》 CSCD 2023年第4期296-303,共8页
Over 20%of mortality during acute liver failure is associated with the development of hepatic encephalopathy(HE).Thus,HE is a complication of acute liver failure with a broad spectrum of neuropsychiatric abnormalities... Over 20%of mortality during acute liver failure is associated with the development of hepatic encephalopathy(HE).Thus,HE is a complication of acute liver failure with a broad spectrum of neuropsychiatric abnormalities ranging from subclinical alterations to coma.HE is caused by the diversion of portal blood into systemic circulation through portosystemic collateral vessels.Thus,the brain is exposed to intestinal-derived toxic substances.Moreover,the strategies to prevent advancement and improve the prognosis of such a liver-brain disease rely on intestinal microbial modulation.This is supported by the findings that antibiotics such as rifaximin and laxative lactulose can alleviate hepatic cirrhosis and/or prevent HE.Together,the significance of the gut-liver-brain axis in human health warrants attention.This review paper focuses on the roles of bacteria metabolites,mainly ammonia and bile acids(BAs)as well as BA receptors in HE.The literature search conducted for this review included searches for phrases such as BA receptors,BAs,ammonia,farnesoid X receptor(FXR),G protein-coupled bile acid receptor 1(GPBAR1 or TGR5),sphingosine-1-phosphate receptor 2(S1PR2),and cirrhosis in conjunction with the phrase hepatic encephalopathy and portosystemic encephalopathy.PubMed,as well as Google Scholar,was the search engines used to find relevant publications. 展开更多
关键词 LIVER Gut-liver-brain axis Bile acids(BAs) Bile acid(BA)receptors Farnesoid X receptor(FXR) Takeda G protein-coupled receptor 5(TGR5) sphingosine-1-phosphate receptor 2 (S1PR2) Brain
原文传递
S1P1在间断禁食抑制慢性脑低灌注大鼠海马星形胶质细胞极化中的作用
10
作者 张淼 高兴红 胡源 《遵义医科大学学报》 2023年第10期921-927,共7页
目的探讨间断禁食对慢性脑低灌注(CCH)大鼠海马星形胶质细胞极化的影响以及S1P1在其中的作用。方法将30只雄性SD大鼠随机分为3组:对照组、CCH组和CCH+间断禁食组。对照组给予假手术,CCH组大鼠给予双侧颈总动脉结扎手术处理,CCH+间断禁... 目的探讨间断禁食对慢性脑低灌注(CCH)大鼠海马星形胶质细胞极化的影响以及S1P1在其中的作用。方法将30只雄性SD大鼠随机分为3组:对照组、CCH组和CCH+间断禁食组。对照组给予假手术,CCH组大鼠给予双侧颈总动脉结扎手术处理,CCH+间断禁食组大鼠在手术后1周开始给予隔日间断禁食处理。术后8周取脑切片,进行C3d/GFAP双重荧光染色,并取新鲜海马组织进行WB检测S1P1、NeuN、PSD95蛋白水平。体外对小胶质细胞系BV2细胞给予慢性浓度梯度氯化钴(48 h)诱导处理,取其条件培养基(MCM)加入原代星形胶质细胞中,qPCR检测各组星形胶质细胞极化标志物表达。将星形胶质细胞条件培养基(ACM)加入神经元细胞系HT22中,CCK8及LDH活性测试检测其毒性,摸索体外慢性缺氧最佳药物浓度。对慢性缺氧诱导的星形胶质细胞给予S1P1抑制剂Ponesimod浓度梯度预处理,观察其是否能抑制星形胶质细胞极化及神经毒性。结果间断禁食可降低慢性脑低灌注大鼠海马C3d/GFAP双重标记细胞数量和S1P1蛋白表达,并恢复慢性脑低灌注引起的NeuN和PSD95蛋白下调(P<0.05)。慢性氯化钴刺激BV2细胞最佳浓度为100μmol/L,刺激后其MCM诱导星形胶质细胞毒性极化标志物C3、Serping1、H2D1转录水平明显增加(P<0.05),且刺激后星形胶质细胞ACM能降低神经元细胞系HT22细胞活性,增加LDH释放(P<0.05)。体外实验发现,10μmol/L浓度Ponesimod能够模拟间断禁食,下调慢性缺氧诱导的星形胶质细胞C3和Serping1转录,并改善慢性缺氧诱导的星形胶质细胞ACM对HT22细胞活性的抑制作用(P<0.05)。结论S1P1可能介导间断禁食对慢性脑低灌注大鼠海马星形胶质细胞毒性极化的抑制作用。 展开更多
关键词 鞘氨醇-1-磷酸受体1 星形胶质细胞极化 间断禁食 大鼠
下载PDF
新型前药类S1P1激动剂Syl978的药理活性 被引量:3
11
作者 金晶 汪小涧 +3 位作者 周琬琪 薛妮娜 尹大力 陈晓光 《中国药科大学学报》 CAS CSCD 北大核心 2014年第3期358-361,共4页
通过对新型免疫抑制剂芬戈莫德(FTY720)的结构改造获得具有全新结构的选择性鞘氨醇-1-磷酸1型受体(sphingosine-1-phosphate receptor 1,S1P1)前药类激动剂Syl978。体外S1P受体激动试验表明:其活性磷酸酯形式Syl978-P对S1P1受体具有显... 通过对新型免疫抑制剂芬戈莫德(FTY720)的结构改造获得具有全新结构的选择性鞘氨醇-1-磷酸1型受体(sphingosine-1-phosphate receptor 1,S1P1)前药类激动剂Syl978。体外S1P受体激动试验表明:其活性磷酸酯形式Syl978-P对S1P1受体具有显著的激动活性,而对于鞘氨醇-1-磷酸3型受体(S1P3)的激动作用较弱,显示良好的受体激动选择性。单次灌胃分别给予SD大鼠0.3,1,3 mg/kg的Syl978都能够显著降低动物外周血淋巴细胞水平,且显示出良好的量效关系。单次灌胃给予SD大鼠10 mg/kg的Syl978对大鼠心率并没有明显影响。研究结果表明,Syl978具有较好的体内外生物活性,具有开发成为治疗自身免疫性疾病药物的良好前景。 展开更多
关键词 鞘氨醇-1-磷酸1型受体 激动剂 Syl978 芬戈莫德 药理活性
下载PDF
Expressions of Sphingosine-1-phosphate (S1P) Receptors, Sphingosine Kinases in Malignant Bone and Soft Tissue Tumors, and The role of Sphingosine Kinase-1 in Growth of MFH Cell Lines
12
作者 Shin-ichiro Kishimoto Toshihiro Akisue +8 位作者 Kenta Kishimoto Hitomi Hara Masaya Imabori Yoshiyuki Okada Naomasa Fukase Teruya Kawamoto Ikuo Fujita Takuya Fujimoto Masahiro Kurosaka 《Journal of Cancer Therapy》 2011年第2期288-294,共7页
Sphingolipids are ubiquitous components of cell membranes. Their metabolites ceramide, sphingosine, and sphingosine-1-phosphate (S1P) have important physiological functions, including regulation of cell growth and sur... Sphingolipids are ubiquitous components of cell membranes. Their metabolites ceramide, sphingosine, and sphingosine-1-phosphate (S1P) have important physiological functions, including regulation of cell growth and survival. S1P is generated by phosphorylation of sphingosine catalyzed by sphingosine kinase-1 (SPHK1). The purpose of this study is to explore the roles of S1P, S1P receptors, and sphingosine kinases in malignant musculoskeletal tumors. Twenty-one tumor samples (7 liposarcomas, 3 chondrosarcomas, 6 osteosarcomas, 5 MFH) obtained at open biopsy, and four human MFH cell lines (Nara H, Nara F, TNMY1, GBS-1) were used. We examined the mRNA expression of S1P receptors by RT-PCR, and the expression levels of SPHK by Real-time PCR. We used 4 MFH cell lines to analyze SPHK1 proteins by Western blotting. SPHK1 siRNA was transfected into MFH cell lines by lipofection method. Cell proliferation (control and transfected with siRNA) was assayed using WST-8 (Cell Counting Kit-8) assay. All high grade malignant tumors expressed S1P1, S1P2, S1P3 receptors, whereas the expression of S1P1 receptor was detected in 50% of low-grade malignant tumors, S1P2 receptor in 30%, and S1P3 in 50%. No statistically significant difference was found in the expression level of SPHK1 between high-grade and low-grade malignant tumors by Real-time PCR. By results of Western blotting, proteins of SPHK1 were expressed in all MFH cell lines. In MFH cell lines, transfection with SPHK1 siRNA oligonucleotides resulted in approximately 50 to 80% suppression of SPHK1 mRNA expression as determined by real-time PCR. Down-regulation of SPHK1 with small interfering RNA significantly reduced SPHK1 protein levels by Western blotting. Knock down of SPHK1 expression significantly decreased cell proliferation of all MFH cells. These results suggest that the expression of S1P receptors may play an important role for cell proliferation and may correlate with histologic grade in malignant bone and soft tissue tumors, and that SPHK1 may be one of essential mo 展开更多
关键词 SARCOMA sphingosine-1-phosphate S1p receptor sphingosine Kinase MIB-1 MFH
下载PDF
1-磷酸鞘氨醇/1-磷酸鞘氨醇受体1与T细胞迁移 被引量:1
13
作者 庄新品 竺青 《药学学报》 CAS CSCD 北大核心 2016年第6期873-878,共6页
脂质第二信使分子1-磷酸鞘氨醇(sphingosine-1-phosphate,S1P)能够与1-磷酸鞘氨醇受体(sphingosine-1-phosphate receptors,S1PRs)结合参与多种生理过程,包括中枢神经系统稳态、细胞因子生成和介导淋巴细胞迁移等。T细胞主要表达S1PR1。... 脂质第二信使分子1-磷酸鞘氨醇(sphingosine-1-phosphate,S1P)能够与1-磷酸鞘氨醇受体(sphingosine-1-phosphate receptors,S1PRs)结合参与多种生理过程,包括中枢神经系统稳态、细胞因子生成和介导淋巴细胞迁移等。T细胞主要表达S1PR1。S1P/S1PR1在T细胞迁移中发挥核心作用,这对于T细胞成熟、归巢和活化具有重要意义。S1P/S1PR1在T细胞迁移中的作用使其成为治疗免疫性疾病的热门药物作用靶点。本综述主要总结了现阶段S1P/S1PR1介导T细胞迁移的相关机制以及作为靶点药物的临床研究进展。 展开更多
关键词 1-磷酸鞘氨醇 1-磷酸鞘氨醇受体1 T细胞迁移 药物靶点
原文传递
鞘氨醇-1-磷酸受体1在疼痛中的作用研究 被引量:1
14
作者 黄金路 万丽丽 郭澄 《中国药理学通报》 CAS CSCD 北大核心 2015年第6期755-759,共5页
鞘氨醇-1-磷酸受体1(sphingosine-1-phosphate receptor1,S1PR1)属于G蛋白偶联受体,其能调节多种下游信号分子和细胞功能。研究发现S1PR1在疼痛中发挥重要作用,但激活S1PR1产生致痛作用还是镇痛作用尚存在争议。该文讨论了S1P/S1PR1信... 鞘氨醇-1-磷酸受体1(sphingosine-1-phosphate receptor1,S1PR1)属于G蛋白偶联受体,其能调节多种下游信号分子和细胞功能。研究发现S1PR1在疼痛中发挥重要作用,但激活S1PR1产生致痛作用还是镇痛作用尚存在争议。该文讨论了S1P/S1PR1信号在疼痛研究中的最新观点与进展,以增进对其生物学功能及病理作用的了解。 展开更多
关键词 疼痛 神经系统 鞘氨醇-1-磷酸受体亚型1 G蛋白偶联受体 鞘氨醇-1-磷酸 FTY720 激动剂
下载PDF
鞘氨醇1磷酸及其受体在粒细胞集落刺激因子诱导造血干/祖细胞动员过程中的表达变化 被引量:1
15
作者 聂胤超 李桥川 +2 位作者 赖永榕 彭志刚 周吉成 《广西医学》 CAS 2015年第6期733-735,共3页
目的探讨鞘氨醇1磷酸(S1P)及其受体在粒细胞集落刺激因子(G-CSF)诱导的造血干/祖细胞(HSPC)动员中的表达变化。方法 6周清洁级雄性C57BL野生型小鼠18只,按随机数字表法分为对照组、动员3 d组、动员5 d组,每组6只。对照组给予腹部皮下注... 目的探讨鞘氨醇1磷酸(S1P)及其受体在粒细胞集落刺激因子(G-CSF)诱导的造血干/祖细胞(HSPC)动员中的表达变化。方法 6周清洁级雄性C57BL野生型小鼠18只,按随机数字表法分为对照组、动员3 d组、动员5 d组,每组6只。对照组给予腹部皮下注射无菌生理盐水100μl/d,连续5 d;动员3 d组连续腹部皮下注射G-CSF 3 d;动员5 d组连续腹部皮下注射G-CSF 5 d。应用流式细胞仪检测3组小鼠外周血Lin-Sca1±c Kit±(LSK)细胞水平,酶联免疫吸附实验(ELISA)检测外周血S1P水平,RT-PCR检测骨髓S1PR1 mRNA水平。结果 LSK细胞水平动员5 d组>动员3 d组>对照组(P<0.05),说明动员成功。动员3 d组外周血S1P水平明显大于动员5 d组、对照组(P<0.05),但动员5 d组与对照组比较,差异无统计学意义(P>0.05)。骨髓S1PR1 mRNA水平动员5 d组>动员3 d组>对照组(P<0.05)。结论在G-CSF诱导的HSPC动员过程中,外周血S1P水平升高以及骨髓S1PR1表达升高,可能有利于G-CSF介导HSPC动员的发生。 展开更多
关键词 造血干细胞 造血祖细胞 鞘氨醇 1 磷酸 鞘氨醇 1 磷酸受体 1 粒细胞集落刺激因子 动员
下载PDF
S1P信号通路在肥厚心肌缺血后适应中的作用 被引量:1
16
作者 李海霞 李晓梅 +5 位作者 陈邦党 刘芬 杨毅宁 盖敏涛 陈小翠 马依彤 《海南医学》 CAS 2015年第1期1-4,共4页
目的探讨在缺血后适应(IPost)减轻肥厚心肌缺血再灌注(IR)损伤中S1P信号通路的作用。方法选取12周龄C57/BL小鼠,利用Langendorff灌流装置建立小鼠肥厚心肌IR模型,30 min全心缺血随后再灌注90 min。64只小鼠随机分为缺血再灌注组(IR组)... 目的探讨在缺血后适应(IPost)减轻肥厚心肌缺血再灌注(IR)损伤中S1P信号通路的作用。方法选取12周龄C57/BL小鼠,利用Langendorff灌流装置建立小鼠肥厚心肌IR模型,30 min全心缺血随后再灌注90 min。64只小鼠随机分为缺血再灌注组(IR组)、缺血后适应组(IPost组)、IPost+W-146组和IPost+PD98059组,每组14只,进行心脏血流动力学和心肌梗死范围检测,Western印迹方法检测S1P1、ERK1/2总蛋白及磷酸化蛋白表达水平。脱氧核苷酸转移酶介导的生物素原位缺口末端标记(TUNEL)法检测心肌细胞的凋亡。结果与IR组比较,IPost组小鼠心脏血流动力学指标左心室收缩压[(66±6)mm Hg vs(85±5)mm Hg]、左室压力上升最大速度[(2 820±220)mm Hg vs(3 778±230)mm Hg]显著降低(P<0.05),心肌梗死范围显著减小[(23.6±2.8)%vs(40.2±4.6)%]。IPost+抑制剂组显示在再灌注的最初15 min使用W-146、PD98059能消除IPost对肥厚心肌的上述保护作用并显著增加心肌梗死面积,与IR组水平相同。与IR组比较,IPost组在再灌注结束后心肌组织中的S1P1、ERK1/2蛋白磷酸化水平表达显著增加;IPost+W-146组与IPost+PD98059组分别与IR组比较,上述指标差异均无统计学意义(P>0.05);TUNEL法检测结果显示,IPost组Bcl-2的表达较其他各组明显升高,Bax的表达较其他各组明显降低,经比较各组之间Bcl-2和Bax的表达差异无统计学意义(P>0.05)。结论 IPost能有效地减轻离体小鼠肥厚心肌缺血再灌注损伤,IPost的心肌细胞保护作用可能是通过S1P结合S1P1后激活ERK1/2信号通路实现的。 展开更多
关键词 S1P S1P1 肥厚心肌 缺血再灌注 缺血后适应
下载PDF
S1P/S1PR2的心血管调节作用及其信号通路 被引量:1
17
作者 鲁艳菊 王双 +1 位作者 伍荣 易光辉 《中国心血管杂志》 2015年第2期158-160,共3页
1-磷酸鞘氨醇(sphingosine 1-phosphate,SIP)是近年来发现的在心血管研究中具有重要生理功能的一种膜磷脂类代谢产物。S1P通过与细胞表面的受体即1-磷酸鞘氨醇受体(sphingosine—1—phosphate reeeptos,S1PRs)作用而发挥其广泛的... 1-磷酸鞘氨醇(sphingosine 1-phosphate,SIP)是近年来发现的在心血管研究中具有重要生理功能的一种膜磷脂类代谢产物。S1P通过与细胞表面的受体即1-磷酸鞘氨醇受体(sphingosine—1—phosphate reeeptos,S1PRs)作用而发挥其广泛的生物学效应。 展开更多
关键词 心血管疾病 1-磷酸鞘氨醇受体2 1-磷酸鞘氨醇
下载PDF
S1P/S1P1信号通路在糖尿病心肌病大鼠心肌损伤中的作用与机制
18
作者 莫海亮 姜佳美 +11 位作者 刘畅 吴子君 黄瑞娜 梁国标 陈科辉 李腾 李上海 闫海 何松坚 游琼 吴铿 郭润民 《中国医药科学》 2017年第15期9-12,共4页
目的探讨S1P/S1P1信号通路在糖尿病心肌病大鼠心肌损伤中的作用与机制。方法 40只SD大鼠分为正常对照组和2型糖尿病心肌病,每组各20只,链脲佐菌素(streptozotocin,STZ)诱导老鼠建立2型DCM模型,STZ处理8周后,给予老鼠S1P1受体激动剂、S1P... 目的探讨S1P/S1P1信号通路在糖尿病心肌病大鼠心肌损伤中的作用与机制。方法 40只SD大鼠分为正常对照组和2型糖尿病心肌病,每组各20只,链脲佐菌素(streptozotocin,STZ)诱导老鼠建立2型DCM模型,STZ处理8周后,给予老鼠S1P1受体激动剂、S1P1受体拮抗剂干预,观察S1P1受体激动剂、S1P1受体拮抗剂对DCM心肌损伤的影响;HE染色检测心肌组织病理改变,免疫印迹法检测心肌组织Sphk1和S1P1的表达,ELISA法检测组织匀浆液S1P的表达,组织Sph K1激酶活性定量检测试剂盒测定Sph K1酶活性。结果与正常对照组比较,DCM组大鼠心脏凋亡增多、心肌肥大,同时Sph K1及其产物S1P表达增加,S1P1受体下调,S1P1受体拮抗剂干预加重DCM心肌损伤,而S1P1受体激动剂能减轻心肌凋亡、心肌肥大、胶原沉积等。结论 S1P/S1P1信号通路被抑制可能是DCM心肌损伤的机制之一,调控该通路可能是DCM心肌损伤的防治靶点。 展开更多
关键词 鞘氨醇激酶-1 1-磷酸鞘氨醇 1-磷酸鞘氨醇受体1 糖尿病心肌病 凋亡
下载PDF
微小RNA-19a-3p对人白血病叉头蛋白O1-Kruppel样因子2-鞘氨醇-1-磷酸受体1通路的影响探析
19
作者 拓进宝 宋超 王丽萍 《世界临床药物》 2022年第2期140-143,共4页
目的探究微小 RNA(miR)-19a-3p 对人白血病叉头蛋白 O1(FoxO1)-Kruppel 样因子(Kruppel like factor,KLF)2-鞘氨醇-1-磷酸受体1(sphingosine-1-phosphate receptor 1,S1P1)通路的影响。方法选取人白血病T淋巴细胞,对细胞进行常规传代培... 目的探究微小 RNA(miR)-19a-3p 对人白血病叉头蛋白 O1(FoxO1)-Kruppel 样因子(Kruppel like factor,KLF)2-鞘氨醇-1-磷酸受体1(sphingosine-1-phosphate receptor 1,S1P1)通路的影响。方法选取人白血病T淋巴细胞,对细胞进行常规传代培养并分为实验组及对照组。实验组通过转染小干扰RNA敲低mi R-19a-3p的表达,对照组不进行任何刺激。检测mi R-19a-3p表达水平,细胞中Fox O1、KLF2、S1P1的表达情况及细胞增殖水平,对比两组相关指标表达情况。结果传代培养后,实验组及对照组细胞mi R-19a-3p表达分别为(2.44±0.21)、(1.53±0.15),差异有统计学意义(P <0.05)。敲低后,实验组Fox O1(35.33±0.89)、KLF2(1.92±0.48)、S1P1(1.45±0.15)表达水平显著高于对照组Fox O1(1.33±0.29)、KLF2(0.66±0.19)、S1P1(0.41±0.09),差异有统计学意义(P <0.05)。两组细胞增殖情况未见明显差异,但实验组较对照组细胞凋亡抑制解除。结论 mi R-19a-3p在淋巴瘤组织中呈现高表达且对人白血病Fox O1-KLF2-S1P1通路有抑制作用,且抑制mi R-19a-3p的高表达可帮助激活Fox O1-KLF2-S1P1通道的正向调控。 展开更多
关键词 微小RNA-19a-3p 人白血病叉头蛋白O1 Kruppel样因子2 鞘氨醇-1-磷酸受体1 细胞通路
原文传递
五步蛇毒蛋白C激活剂在脓毒症大鼠早期适应性免疫应答中的作用
20
作者 孙瑶 包鹏举 +2 位作者 张根葆 王海华 王国栋 《南方医科大学学报》 CAS CSCD 北大核心 2021年第4期514-520,共7页
目的探讨五步蛇毒蛋白C激活剂(PCA)在脓毒症大鼠早期适应性免疫应答中的作用。方法采用SPF级SD大鼠78只,用随机数字表法分组:对照组(n=6,腹腔注射生理盐水);通过腹腔注射脂多糖(LPS 10 mg/kg)复制脓毒症大鼠模型,模型组以LPS注射后4、6... 目的探讨五步蛇毒蛋白C激活剂(PCA)在脓毒症大鼠早期适应性免疫应答中的作用。方法采用SPF级SD大鼠78只,用随机数字表法分组:对照组(n=6,腹腔注射生理盐水);通过腹腔注射脂多糖(LPS 10 mg/kg)复制脓毒症大鼠模型,模型组以LPS注射后4、6、8、12、16、24 h时的标本采集时间分为6组,6只/组;余36只大鼠于LPS注射30 min后使用药物干预,分为1-磷酸鞘氨醇受体1(S1PR1)激动剂SEW2871干预组(0.5 mg/kg,腹腔注射)和PCA干预组(0.1 mg/kg,腹腔注射),各干预组以LPS注射后6、12、24 h时的标本采集时间分为3组,每组6只。采用ELISA法检测血浆IL-4、S1P、IL-12和IFN-γ水平,应用免疫荧光法检测肠系膜淋巴结S1PR1和CD103表达的变化。结果与对照组比较,脓毒症大鼠在注射LPS后的24 h内,血浆S1P、IL-12、IL-4和IFN-γ水平明显增高(P<0.05),LPS注射后6 h内IFN-γ/IL-4比值逐渐增高,之后逐渐降低;肠系膜淋巴结中S1PR1和CD103的表达明显增高(P<0.05)。SEW2871明显增加血浆S1P、IL-12和IFN-γ的浓度,降低血浆IL-4水平(P<0.05),且明显减少淋巴结中S1PR1和CD103的表达(P<0.05)。蛇毒PCA干预后,血浆IL-4水平明显增高,淋巴结S1PR1表达显著增多(P<0.05)。结论五步蛇毒PCA对维持脓毒症早期机体炎症和免疫反应的平衡具有调节作用,其机制可能与S1P-S1PR1通路有关。 展开更多
关键词 脓毒症 适应性免疫应答 1-磷酸鞘氨醇 1-磷酸鞘氨醇受体1 五步蛇毒 蛋白C激活剂
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部